Trial Of Azithromycin In Campylobacter Concisus Patients With Diarrhea
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled clinical trial of azithromycin in
Campylobacter concisus culture positive patients with diarrhea. The clinical characteristics
of emerging Campylobacter concisus in adults is vomiting and persistent diarrhea. Whether
patients may benefit from antibiotic treatment is unknown. The purpose of this trial is to
investigate whether antibiotic treatment with azithromycin of Campylobacter concisus induced
diarrhea can better the symptoms and shorten the duration of illness.
Phase:
Phase 3
Details
Lead Sponsor:
University of Aarhus
Collaborators:
Aalborg Universitetshospital Aalborg University Hospital Slagelse Hospital